Skip to main content
. 2018 Apr 11;18:407. doi: 10.1186/s12885-018-4224-x

Fig. 2.

Fig. 2

The proliferation of A549 cells treated with bexarotene, bexarotene + slc10a2-shRNA, bexarotene + slc10a2-overexpression respectively. A549 cells without treatment as control. All experiments were repeated 3 times